EU Cannabis Regulations

In-depth regulatory guides covering cannabis trade, medical frameworks, legal standards, and business compliance across the European Union. Essential reading for operators, investors, and compliance professionals navigating the European cannabis market.

3
Trade & Transport
Cross-border trade, import/export rules, and transport regulations across the EU
2
Medical & Research
Clinical trials, medical cannabis frameworks, and drug monitoring in Europe
3
Legal Frameworks
THC limits, advertising restrictions, and harmonization efforts across EU member states
4
Business & Compliance
GMP certification, GACP standards, packaging requirements, and hemp regulations

Trade & Transport

Cross-border trade, import/export rules, and transport regulations across the EU

Medical & Research

Clinical trials, medical cannabis frameworks, and drug monitoring in Europe

Legal Frameworks

THC limits, advertising restrictions, and harmonization efforts across EU member states

Business & Compliance

GMP certification, GACP standards, packaging requirements, and hemp regulations

Explore More

Frequently Asked Questions

How is cannabis regulated in the European Union?
Cannabis regulation in the EU is primarily a matter of national competence, meaning each member state sets its own laws. However, EU-level frameworks affect key areas: the Common Agricultural Policy governs hemp cultivation (up to 0.3% THC), the Novel Food Regulation applies to CBD products, pharmaceutical directives regulate medical cannabis, and the Single Convention on Narcotic Drugs applies to cross-border trade. The result is a patchwork of national laws with some EU-level coordination on specific aspects.
Is medical cannabis legal across the EU?
Over 20 EU member states have some form of medical cannabis program, but the scope, accessibility, and product range vary enormously. Germany has the largest and most developed medical cannabis market in Europe, followed by Italy, the Netherlands, and Denmark. Some countries offer comprehensive programs with insurance reimbursement, while others have very limited programs restricted to specific conditions or pharmaceutical preparations.
What is needed to sell CBD products in Europe?
Selling CBD as a food product or supplement in the EU requires novel food authorization under Regulation (EU) 2015/2283. Applications are assessed by EFSA and typically cost 300,000-500,000 euros. CBD in cosmetics follows the Cosmetic Products Regulation and requires CPNP notification. THC content limits for CBD products vary by country, ranging from near-zero in France and Belgium to 1.0% in the Czech Republic and Switzerland. Packaging must comply with country-specific labeling requirements, and health claims about CBD are prohibited.
Can cannabis be traded freely between EU member states?
No. Despite the EU's single market principles, cannabis as a controlled substance requires import and export permits for every cross-border transaction between member states. Each shipment requires matching permits from both countries' competent authorities, monitored by the International Narcotics Control Board. Products must meet GMP standards and pharmacopoeia requirements in the destination country. Hemp fiber and seed products face fewer restrictions but CBD-containing materials require additional documentation.
What certifications do cannabis businesses need in Europe?
For medical cannabis: EU GMP certification (EudraLex Volume 4) is essential for manufacturing, costing 500,000 to several million euros. GACP certification is required for pharmaceutical-grade cultivation. For CBD products: novel food authorization, cosmetic product notification (CPNP), and compliance with country-specific labeling and advertising rules. Industrial hemp farmers need to use EU Common Catalogue varieties and maintain CAP compliance documentation.